MwanzoHLUBF • OTCMKTS
add
H Lundbeck A/S Class A
Bei iliyotangulia
$ 4.82
Bei za mwaka
$ 4.59 - $ 6.41
Thamani ya kampuni katika soko
41.19B DKK
Wastani wa hisa zilizouzwa
20.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CPH
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (DKK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 6.09B | 9.96% |
Matumizi ya uendeshaji wa biashara | 4.36B | 12.55% |
Mapato halisi | -27.00M | -104.58% |
Kiwango cha faida halisi | -0.44 | -104.13% |
Mapato kwa kila hisa | 0.94 | -30.88% |
EBITDA | 956.00M | -2.65% |
Asilimia ya kodi ya mapato | 107.50% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (DKK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.43B | -26.39% |
Jumla ya mali | 52.05B | -9.72% |
Jumla ya dhima | 27.15B | -16.84% |
Jumla ya hisa | 24.90B | — |
hisa zilizosalia | 991.23M | — |
Uwiano wa bei na thamani | 0.19 | — |
Faida inayotokana na mali | 2.33% | — |
Faida inayotokana mtaji | 3.31% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (DKK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -27.00M | -104.58% |
Pesa kutokana na shughuli | 921.00M | 179.81% |
Pesa kutokana na uwekezaji | -202.00M | 98.65% |
Pesa kutokana na ufadhili | -765.00M | -106.15% |
Mabadiliko halisi ya pesa taslimu | -46.00M | 98.74% |
Mtiririko huru wa pesa | 944.38M | -46.59% |
Kuhusu
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
14 Ago 1915
Tovuti
Wafanyakazi
5,039
